Working together to make the world a healthier place: Desiderata for the pharmaceutical industry

Cambridge Quarterly of Healthcare Ethics 28 (1):153-164 (2019)
  Copy   BIBTEX

Abstract

Cross-sectorial, dynamic, and innovative partnerships are essential to resolve the challenges of humankind in the 21st century. At the same time, trust in each other’s integrity and good will is a precondition for the solution of any complex problem, and certainly for the success of the United Nations Sustainable Development Agenda. Experience shows that a nation’s economic and social success is at its greatest if, and when, there is cooperation and even cocreation involving a fair division of labor and responsibility among the different societal stakeholders. This paper uses Ralf Dahrendorf’s seminal work on obligations, as well as the European Commission’s Science with and for Society unit’s definition of responsible research and innovation (RRI), to motivate industry responsibilities to make the world a healthier place.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.

Analytics

Added to PP
2018-11-09

Downloads
34 (#459,882)

6 months
6 (#512,819)

Historical graph of downloads
How can I increase my downloads?